Virovance Revenue

Biotechnology Research • Rockville, Maryland, United States • 1-10 Employees

Virovance revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at Virovance

Avery Wilson

Founder

Company overview

Headquarters	Rockville, Maryland, United States
Website	virovance.com
NAICS	541714
Founded	2025
Employees	1-10

About Virovance

Welcome to Virovance Inc., where innovation meets determination in the fight against cancer. As a pioneering oncology-focused biotechnology company, we specialize in the development of small-molecule therapeutics designed to target the most challenging cancers. At Virovance, we leverage cutting-edge scientific research and collaborate with industry leaders in artificial intelligence (AI) to accelerate drug discovery and development. By outsourcing advanced AI-driven computational models, we enhance our ability to identify, optimize, and develop life-saving therapeutics efficiently and effectively. Our mission is simple yet ambitious: to revolutionize cancer treatment through precision medicine and provide patients with transformative solutions that improve survival rates and quality of life. Virovance is committed to making a meaningful impact in the oncology landscape. Together, we’re redefining what’s possible in cancer care. Explore our journey and join us in shaping the future of oncology.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Virovance has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Virovance has never raised funding before.

Frequently asked questions

Virovance is located in Rockville, Maryland, US.

Virovance generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

Virovance has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Virovance was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Virovance has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Virovance

Avery Wilson

Founder

4.8

40,000 users